Cardiovascular clinical trials in the era of a pandemic

COVID‐19 has reached pandemic levels in March 2020 and impacted public health with unpredictable consequences.(1, 2) The conduct of clinical research in areas unrelated to COVID‐19 has been disrupted and will be further affected. Researchers, trial participants and study personnel have to overcome c...

Descripción completa

Detalles Bibliográficos
Autores principales: Siontis, George CM, Sweda, Romy, Windecker, Stephan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7763388/
https://www.ncbi.nlm.nih.gov/pubmed/32993467
http://dx.doi.org/10.1161/JAHA.120.018288
_version_ 1783628006744391680
author Siontis, George CM
Sweda, Romy
Windecker, Stephan
author_facet Siontis, George CM
Sweda, Romy
Windecker, Stephan
author_sort Siontis, George CM
collection PubMed
description COVID‐19 has reached pandemic levels in March 2020 and impacted public health with unpredictable consequences.(1, 2) The conduct of clinical research in areas unrelated to COVID‐19 has been disrupted and will be further affected. Researchers, trial participants and study personnel have to overcome challenges to sustain proper and safe conduct of clinical trials (i.e. logistical challenges, lower enrollment than expected, difficulties in follow‐up and outcome assessment/adjudication, incomplete data collection, research funding prolongation).
format Online
Article
Text
id pubmed-7763388
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-77633882020-12-28 Cardiovascular clinical trials in the era of a pandemic Siontis, George CM Sweda, Romy Windecker, Stephan J Am Heart Assoc Research Letter COVID‐19 has reached pandemic levels in March 2020 and impacted public health with unpredictable consequences.(1, 2) The conduct of clinical research in areas unrelated to COVID‐19 has been disrupted and will be further affected. Researchers, trial participants and study personnel have to overcome challenges to sustain proper and safe conduct of clinical trials (i.e. logistical challenges, lower enrollment than expected, difficulties in follow‐up and outcome assessment/adjudication, incomplete data collection, research funding prolongation). John Wiley and Sons Inc. 2020-10-09 /pmc/articles/PMC7763388/ /pubmed/32993467 http://dx.doi.org/10.1161/JAHA.120.018288 Text en © 2020 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Research Letter
Siontis, George CM
Sweda, Romy
Windecker, Stephan
Cardiovascular clinical trials in the era of a pandemic
title Cardiovascular clinical trials in the era of a pandemic
title_full Cardiovascular clinical trials in the era of a pandemic
title_fullStr Cardiovascular clinical trials in the era of a pandemic
title_full_unstemmed Cardiovascular clinical trials in the era of a pandemic
title_short Cardiovascular clinical trials in the era of a pandemic
title_sort cardiovascular clinical trials in the era of a pandemic
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7763388/
https://www.ncbi.nlm.nih.gov/pubmed/32993467
http://dx.doi.org/10.1161/JAHA.120.018288
work_keys_str_mv AT siontisgeorgecm cardiovascularclinicaltrialsintheeraofapandemic
AT swedaromy cardiovascularclinicaltrialsintheeraofapandemic
AT windeckerstephan cardiovascularclinicaltrialsintheeraofapandemic

Ejemplares similares